ISPE Biotech 2025

ISPE Biotechnology Conference 2025 Recap

📋 Summary: AI-based tools and methods are being integrated across the facility lifecycle, balancing cost, quality, and speed. Highlights included discussions on leveraging AI/ML for quality improvement, building cultures of innovation, and global regulatory harmonization efforts.

Day 1 Highlights

• Opening Remarks: Silas Tamufor celebrated ISPE Boston Area Chapter’s grant program.

• Emerging AI/ML in Quality: Michael de la Torre discussed unifying data across workflows, moving beyond isolated point solutions, and future regulatory integration challenges.

• AI Tools in Deviations & SOPs: Presentations covered deviation digital assistants, SOP transformation tools, and natural language search applications transforming deviation management and compliance documentation.

Day 2 Highlights

• Culture of Innovation Panel: Led by Sean Keenan, panelists shared strategies on clear roles, departmental rotation, and building accountability.

• Global Regulatory Harmonization: Tim Watson emphasized that regulatory frameworks shouldn’t stifle innovation and highlighted efforts in global harmonization of drug approvals.

• Facility Strategies: Discussions on modular facility design, cost versus speed tradeoffs, and the importance of minimizing delays to optimize operational readiness.

Throughout both days, themes of data integrity, leveraging AI for efficiency, and balancing cost, quality, and speed were consistently reinforced.

View the full linked in post here.